Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

NCT04044651 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Bristol-Myers Squibb company terminated this study

Conditions

Interventions

Sponsor

Shi Ming

Collaborators